INTRODUCTION
============

Chronic kidney disease (CKD) is an alarming health problem affecting millions of people worldwide, ([@b44-jer-15-3-472]) with a global prevalence of around 10% ([@b29-jer-15-3-472]), this rate increased with age advance ([@b25-jer-15-3-472]). The CKD; with the urgency for maintenance renal hemodialysis (MRH) is a globally debilitating problem. There's a continuous annual rise in the incidence of end-stage renal disease ([@b23-jer-15-3-472]), that is accompanied by increasing the number of patients on MRH ([@b13-jer-15-3-472]).

Patients with CKD are generally suffering reduced activity level ([@b26-jer-15-3-472]), and muscle weakness that are all resulting in impaired physical function and loss of balance during everyday tasks ([@b14-jer-15-3-472]), which are major contributors for increased mortality in patients with CKD ([@b5-jer-15-3-472]).

Easy fatigability, altered physical performance (PP) ([@b30-jer-15-3-472]), reduced exercise training frequency ([@b50-jer-15-3-472]), and increased tendency to be inactive ([@b4-jer-15-3-472]) are prominent features in patients on MRH, resulting in functional and physical impairments ([@b31-jer-15-3-472]) that are manifested mainly in deteriorated performance of the tasks of daily living activities (ADL) ([@b28-jer-15-3-472]) and increased mortality rates in patients on MRH; the concept that clarifies the importance of implementing the exercise therapy as an essential component of the program of care for patients on MRH ([@b50-jer-15-3-472]).

Effective strategies are required to modify the cardiovascular risk factors that are commonly encountered in patients on MRH ([@b41-jer-15-3-472]). Patients' PP and functional balance (FB) are still the focus of interest of health care providers for patients on MRH ([@b55-jer-15-3-472]). Previous studies showed that exercise training has favorable effects on functional capacity and cardiovascular risk factors in those populations ([@b16-jer-15-3-472]).

In spite of the continuously expanding body of knowledge regarding the benefits of exercise training in patients on MRH; further investigations are required to fully clarify the effects of exercise training in those patients ([@b27-jer-15-3-472]) through large samples and long duration studies ([@b1-jer-15-3-472]). Until recently; little is known about long-term effects of either aerobic or resistance exercise training on PP and FB. There is a continuous need to establish well-designed studies that provide detailed exercise prescription for patients on MRH. Furthermore; explanations are continuously warranted to describe the optimal benefits of aerobic and resistance exercise training in those populations, so the aim of this study as an extension to the previously published works in this field was to objectively evaluate the effects of aerobic and resistance exercise training on the PP and the FB in patients on MRH.

MATERIALS AND METHODS
=====================

Subjects
--------

Eighty-Seven eligible volunteer patients on MRH were recruited to be enrolled in this study. Twenty-one patients were withdrawn and excluded before randomization and group allocation. The remaining 66 patients (36 males: 30 females) participated and completed this study ([Fig. 1](#f1-jer-15-3-472){ref-type="fig"}). The G-power program was used to determine the sample size in which the effect size=0.42, α=0.05, power (1-β error probability)=0.82%, with the number of groups=3, producing a total number of 63 participants to be enrolled in this study. Inclusion criteria: patient on MRH for more than 2 years due to CKD, age 35--45 years old, and agreed to sign an informed consent for participation in the study. Exclusion criteria: participation in any previous exercise training program in the last 6 months, active infection within the last 4 weeks, body mass index (BMI) ≥35 kg/m^2^, history of angina pectoris, lower limb amputation, chronic cardiovascular or pulmonary disorders interfering with patient safety and study results, history of the cerebrovascular or musculoskeletal insults that can affect the patient performance and accuracy of the study results.

Study procedures
----------------

All participants underwent the same battery of tests, were fully aware of the study goals and procedures, agreed to participate in this study and signed written informed consent at the beginning of this study that was carried out between May 2017 and November 2018, according to the principles of the Declaration of Helsinki 1975, revised Hong Kong 1989 and was approved by the institutional ethics committee of the Faculty of Physical Therapy, Cairo University (approval number No: P.T.REC/012/002123).

The nature of the study did not allow full blinding except for the evaluator and the data manager. After medical screening; 66 eligible patients were randomly allocated (using a computer program SAS Proc Plan; SAS Institute Cary NC, USA) into one of the three groups: the aerobic exercise training group (AETG; n= 20), the resistance exercise training group (RETG; n=21), and the control group (CG; n=25). All participants were encouraged to stabilize their medical treatment and the dialysis regimen throughout the study.

Outcome measures
----------------

The primary variables were the PP (evaluated using the 6-min walk test "6MWT") in meter, and the FB (evaluated using the Berg balance scale "BBS"). Each variable was evaluated at 3 time-points throughout the study: prestudy (evaluation-1), after 3 months (evaluation-2) and 2 months poststudy cessation (evaluation-3). Demographic characteristics including weight, height and BMI were assessed using portable stadiometer (Detecto's ProMed 6129 medical scale, 203 E. Daugherty, Webb City, MO, USA). Resting heart rate (HR rest), systolic and diastolic blood pressure were evaluated from non-fistula arm using digital sphygmomanometer; (BTL CardioPoint ABPM apparatus "BTL Science and Technology \[Shenzhen\] Co., Ltd, China") following established guidelines ([@b57-jer-15-3-472]).

Maximum heart rate (HRmax) was assessed through the modified symptom-limited Bruce exercise testing protocol using a standard stress testing instrument, (Cardiac Science Quinton Q-Stress Test system, Cardiac Science International A/S, Kirke Vaerloesevej 14, DK-3500 Vaerloese, Dänemark) following established guidelines ([@b36-jer-15-3-472]). While the patient was closely monitored; the exercise testing started with 1.8 miles per hour speed, zero % inclination, both of which were gradually increased until exhaustion or the appearance of electrocardiogram abnormalities.

PP evaluation
-------------

After proper explanation of the test procedure; evaluation of PP was performed using the 6MWT. Following previously published guidelines ([@b33-jer-15-3-472]); each participant walked in his/her own maximal pace through the 30 meter corridor for 6-minutes while putting-on the wireless fingertip pulse oximeter (INC013 China Rechargeable Handheld CMS 50I Contec Ear Fingertip Pulse Oximeter, ICEN Technology Company Limited, Amydimed, Guangdong China) to monitor the heart rate (HR), the covered distance was then recorded in meters at the end of the 6th minutes.

FB evaluation: (evaluated via the "BBS")
----------------------------------------

The FB was evaluated using the "BBS", consisted of 14 items, each item score ranges from zero (the lowest level of function) to four where (the highest level of performance). Activities performed in the BBS varied in difficulty from setting, to standing, to standing on one leg. The used materials included standard chairs (one with arm rests, one without), 15 ft walkway, a stopwatch, a step and a ruler. Participant was asked to follow instructions in maintaining their balance while holding on certain position for specified time or achieving the requested task. The FB evaluations and data collection were done by the same examiner following standard guidelines ([@b6-jer-15-3-472]).

Interventions
-------------

Each patient adhered to his/her prescribed training program; no serious abnormalities were recorded throughout the study.

Aerobic exercise training program
---------------------------------

Each participant in this group (n=20) received twelve weeks of gradually progressive aerobic exercise training (AET) three times/week, on the nondialysis day's session schedule. Sufficient time (2--3 hours) was allowed after the breakfast before starting the session to avoid hypoglycemia.

After conducting a preliminary session to familiarize the patients on the treadmill and ensure safety measures during training; each session started and ended with 5 to 10 min warm-up/cool-down in the form of quite walking on the treadmill at intensity of 50% HRmax. The exercise training intensity was closely monitored using the wireless pulse oximeter (IN-C013 China Rechargeable Handheld CMS 50I Contec Ear Fingertip Pulse Oximeter, ICEN Technology Company Limited, Amydimed, Guangdong, China) worn by the patient and via the 15 points Borge's scale of perceived exertion.

The duration and intensity of the AET were gradually adjusted at regular intervals. The training duration started with 30 min and gradually increased to reach 45 min at the end of the study. The training intensity started with 55% HRmax, reached 70% HRmax at the end of the study ([Table 1](#t1-jer-15-3-472){ref-type="table"}). Participants in the AETG were continuously directed to maintain their rate of perceived exertion between 11 and 13 on the Borge's scale.

Resistance exercise training program
------------------------------------

The closely supervised resistance training was conducted 3 times weekly for 12 weeks. The program consisted of leg curl and leg extension exercises using Kettler 7752-800 multigym machine, EMS Physio (UK). Each session was preceded and followed by a warm-up/cool down phase typically as for the AETG.

The resistance training was conducted following previously published guidelines ([@b1-jer-15-3-472]; [@b54-jer-15-3-472]). The training was started with two sets of eight repetitions 70% one-repetition maximum (1RM) and progress to reach three sets of ten repetitions 70% 1RM ([Table 1](#t1-jer-15-3-472){ref-type="table"}). The training resistance was adjusted according to the newly achieved 1RM. The process of 1RM re-evaluation and resistance adjustment was performed every 2 weeks. Participants in this group (n=21) were directed to maintain their rate of perceived exertion between 15--17 on the Borge's scale throughout the study.

Control group
-------------

Twenty-five participants were directed to maintain their regular medical care and their usual physical activity throughout the study but did not participate in any exercise training.

Statistical analysis
--------------------

Data analysis was performed using IBM SPSS Statistics ver. 20.0 (IBM Co., Armonk, NY, USA) data are presented as mean and standard deviations. The Kolmogorov--Smirnov test was conducted to test data normal distribution. Changes in the PP and the FB mean values within and between groups at the three evaluation points were analyzed using the repeated measures analysis of variance with pairwise comparisons, with two "within-subjects" factors; treatment (AET, RET, control) and time (evaluation-1, evaluation-2, evaluation-3) to test hypothesis within and between groups. The level of significance was set at *P*\<0.05.

RESULTS
=======

Eighty-Seven patients were recruited to participate in this study, only 66 participants enrolled and completed the study and were randomly allocated to either the AETG (n=20), RETG (n=21), or CG (n=25) ([Fig. 1](#f1-jer-15-3-472){ref-type="fig"}).

Demographic characteristics
---------------------------

[Table 2](#t2-jer-15-3-472){ref-type="table"} shows the patients' characteristics at the beginning of the study. There were nonsignificant differences between groups in the age (year), body weight (kg), height (m), BMI (kg/m^2^), systolic blood pressure (mmHg), diastolic blood pressure (mmHg), Hours of dialysis per week, and average length of the hemodialysis vintage (months) (*P*\>0.05) ([Table 2](#t2-jer-15-3-472){ref-type="table"}).

Within group's comparison
-------------------------

### At evaluation-2

Results revealed that there were significant increases in mean values of PP by 33.1%, 22.52% and FB by 22.95%, 22.25% for the AETG and the RETG groups, respectively (*P*\<0.01), compared with nonsignificant decreases in the PP (0.33%; *P*=0.17) and the FB (0.09%; *P*=0.76) mean values in the CG ([Table 2](#t2-jer-15-3-472){ref-type="table"}).

### At evaluation-3

Within the group's comparison between the evaluation-2 and −3 time points revealed that there were significant reduction in the mean values of the PP by 4.33%, 10.93% and the FB by 11.29%, 13.98% for the AETG and the RETG groups, respectively (*P*\<0.01), compared with nonsignificant decrease in the PP (*P*=0.61) and the FB (*P*=0.06) mean values in the CG. Within the group's comparison between the evaluation-1 and −3 time points revealed that there were significant increases in the mean values of the PP by 27.36%, 8.5% and the FB by 8.06%, 5% for the AETG and the RETG groups, respectively (*P*\<0.01), compared with nonsignificant reduction in the PP (*P*=0.1) and the FB (*P*=0.07) mean values in the CG ([Table 3](#t3-jer-15-3-472){ref-type="table"}).

Between groups' comparison
--------------------------

### At evaluation-1

Results revealed that there were non-significant differences in the PP (*P*=0.5) and the FB (*P*=0.83) mean values.

### At evaluation-2 and-3

Results revealed that there were significant differences in the PP and the FB mean values, but in favor of the AETG group (*P*\<0.01) ([Table 4](#t4-jer-15-3-472){ref-type="table"}; [Figs. 2](#f2-jer-15-3-472){ref-type="fig"}, [3](#f3-jer-15-3-472){ref-type="fig"})

DISCUSSION
==========

The results of this study confirmed the importance of applying regular aerobic as well as strength training in patients on MRH. Aerobic as well as strength training proved to have favorable short and long-term effects on the PP and the FB in patients on MRH. The current study investigated short as well as long-term responses of the PP and the FB to exercise therapy in patients on MRH.

Factors led to the reduction of physical activity level in patients on regular MRH include decreased muscle strength ([@b30-jer-15-3-472]), increased co-morbidities ([@b47-jer-15-3-472]), and deteriorated physiological status ([@b19-jer-15-3-472]). The importance of implementing the exercise training in the treatment of patient with CKD is not a recent concept ([@b22-jer-15-3-472]). Previous studies reported physical as well as psychological benefits of exercise training in patients on MRH ([@b21-jer-15-3-472]; [@b20-jer-15-3-472]; [@b24-jer-15-3-472]). Pervious works reported that the benefits of regular exercise training included increased hemoglobin level, reduced hyperinsulinemia, and reduced the triglyceride level as well as limiting the depressive symptoms ([@b21-jer-15-3-472]), all of which can positively impact the PP in patients on MRH.

Investigating the effects of resistance exercise training gained relatively lesser attention than that of AET in patients on MRH, furthermore; the majority of these investigations evaluated the short-term effects of training and were done during the hemodialysis sessions. Despite its proven benefits; exercise training in patients on MRH is rarely conducted on a regular basis ([@b2-jer-15-3-472]). Furthermore; data on short and long-term effects of exercise training in patients on MRH became mandatory to implement these training programs in the routine practical care of those patients ([@b10-jer-15-3-472]; [@b56-jer-15-3-472]).

The significant increases in the PP and the FB in patients on MRH in this study are comparable to results reported in previous studies. Patients on regular MRH are usually suffering reduced work capacity that can be efficiently improved by exercise practice ([@b14-jer-15-3-472]; [@b42-jer-15-3-472]). Earlier study by [@b15-jer-15-3-472], showed that exercise training for 3 months significantly increased the already deteriorated work capacity and muscle strength in patients with CKD. Muscular strength can be significantly improved after twenty weeks ([@b18-jer-15-3-472]) or after 4 months of aerobic training in patients with CKD ([@b9-jer-15-3-472]). Both aerobic and resistance exercise training in the form of 2-sessions/wk for 3 months can significantly increase the walking distance in patients with CKD ([@b46-jer-15-3-472]). Exercise training proved to reduce bodily pain and depression in addition to enhancing the self-esteem in patients on MRH ([@b39-jer-15-3-472]).

The significant increase in the PP in response to exercise training is mainly represented in shortening the time required to perform functional tasks in patients on MRH and can be attributed to increased muscular endurance ([@b7-jer-15-3-472]), increased VO~2~max ([@b3-jer-15-3-472]), and improved muscle power ([@b12-jer-15-3-472]). Exercise training has cardiovascular benefits as well, exercise training improves the left ventricular mass index and hence; increasing cardiac output and ejection fraction in patients on MRH ([@b17-jer-15-3-472]). Regular exercise training can significantly improve the walking capacity and the tasks achievement time in patients on MRH ([@b37-jer-15-3-472]), considering that AET with sufficiently higher intensity and longer study duration showed more favorable results on functional capacity than lower intensity and shorter duration training ([@b17-jer-15-3-472]; [@b34-jer-15-3-472]; [@b43-jer-15-3-472]).

Earlier studies reported that CKD is associated with progressive loss of strength in the large body muscles ([@b32-jer-15-3-472]; [@b49-jer-15-3-472]). Regarding the PP and the FB responses to resistance exercise training in patients on MRH; results of current study can be explained on the basis of the concept that strength training of 3- to 6-month increases the strength of large, proximal lower limbs muscles ([@b1-jer-15-3-472]; [@b12-jer-15-3-472]; [@b48-jer-15-3-472]), increase muscle size ([@b11-jer-15-3-472]) and produces concurrent improvements in knee extensor strength and performance of ADL ([@b12-jer-15-3-472]). The underlying mechanisms of noticeable improvments on patients on MRH in response to exercise training are numerous, including the significant reduction in the number of atrophic lower limb muscles fibers and accompanied increase in its cross-sectional area especially in type II muscle fibers ([@b35-jer-15-3-472]), significant reduction in inflammatory markers and improvement in body composition ([@b40-jer-15-3-472]). The post-training physical improvments in patients on MRH can be partly explained by the training-related increase in the protein synthesis ([@b8-jer-15-3-472]; [@b45-jer-15-3-472]), increasing blood flow to the exercised muscles ([@b38-jer-15-3-472]) and the favorable adaptations within the skeletal muscles in response to the provided training in patient on MRH ([@b35-jer-15-3-472]; [@b53-jer-15-3-472]). The exercise training counteracts the state of muscle atrophy presented in patients on MRH and so reducing the incidence of muscular fatigue and produces significant improvments in ADL acheivments ([@b52-jer-15-3-472]). Adding to that; the effects of regular exercise etraining are not limited to physical aspects but extends to include psychological aspects as well. Regular exercise training even for a short time proved to significantly improve the emotional status and health related quality of life ([@b51-jer-15-3-472]) and hence positively impacting the regular participation and the PP of various activities in patients on MRH.

Some limitations were encountered in the current study. Efforts were done to avoid bias and to optimize blinding, but the nature of the study limits the double blinding process since both patients and physiotherapist should know the group allocation and the type of the exercise training. Absence of combined aerobic plus strength exercise training group, relatively short follow-up duration are additional limitations. Future studies should try to overcome these limitations. In conclusion; both AET and RET have extended favorable effects on the PP and FB in patients on MRH. The AET showed higher short and long-term favorable effects than the RET on the PP and FB in patients on MRH. So the AET is still the recommended approach to improve the PP and FB in patients on MRH.
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###### 

The parameters of the aerobic and resistance exercise training programs

  Training              Weeks    Duration                               Intensity
  --------------------- -------- -------------------------------------- -----------------------------------
  Aerobic training      1--3     30 min                                 55% HRmax
  4--6                  35 min   60% HRmax                              
  7--9                  40 min   65% HRmax                              
  10--12                45 min   70% HRmax                              
                                                                        
  Resistance training   1--2                                            Two sets of 8 repetitions 70% 1RM
  3--4                           Three sets of 8 repetitions 70% 1RM    
  5--6                           Two sets of 9 repetitions 70% 1RM      
  7--8                           Three sets of 9 repetitions 70% 1RM    
  9--10                          Two sets of 10 repetitions 70% 1RM     
  11--12                         Three sets of 10 repetitions 70% 1RM   

HRmax, maximum heart rate; 1RM, one-repetition maximum.

###### 

The demographic characteristics of participants of all groups

  Variable                                  AETG (n=20)   REG (n=21)    CG (n= 25)    *T*-value   *P*-value
  ----------------------------------------- ------------- ------------- ------------- ----------- ------------
  Age (yr)                                  39.9±3.75     39.67±4.07    40.12±2.86    0.09        0.91^\*\*^
                                                                                                  
  Weight (kg)                               76.35±7.98    75.81±9.47    75.88±7.06    0.03        0.97^\*\*^
                                                                                                  
  Height (m)                                1.68±0.09     1.67±0.1      1.68±0.08     0.16        0.85^\*\*^
                                                                                                  
  BMI (kg/m^2^)                             27.07±2.62    27.32±2.68    27.17±3.28    0.40        0.96^\*\*^
                                                                                                  
  SBP (mmHg)                                145.3±2.58    144.76±2.79   145.64±2.78   0.60        0.55^\*\*^
                                                                                                  
  DBP (mmHg)                                93.1±1.12     92.95±1.57    92.92±1.71    0.90        0.92^\*\*^
                                                                                                  
  Length of the hemodialysis vintage (mo)   38.3±8.13     37.86±8.77    38.16±7.26    0.02        0.98^\*\*^
                                                                                                  
  Hours of dialysis/wk                      14.5±3.05     14.67±2.61    15.04±2.32    0.25        0.78^\*\*^
                                                                                                  
  HRmax (beat/min)                          151.55±3.28   151.24±3.77   150.6±3.42    0.44        0.65^\*\*^
                                                                                                  
  CKD etiology (%)                                                                                
   Hypertension                             7             6             9                         
   Glomerul-onephritis                      8             10            9                         
   Unknown/others                           5             5             7                         
                                                                                                  
  Smoking history                                                                                 
   Smoker:ex-smoker:nonsmoker               5:9:6         7:8:6         7:12:6                    
                                                                                                  
  Gender                                                                                          
   Female:male                              10:10         11:10         15:10                     

AETG, aerobic exercise training group; REG, resistance exercise training group; CG, control group; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HRmax, maximum heart rate; CDK, chronic kidney disease.

*P*\<0.05, statistically significant difference.

###### 

Physical performance and functional balance of all groups

                             AETG (n=20)                                                    RETG (n=21)                                                                                                 CG (n=25)                                                                                                                                                                                         
  -------------------------- -------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------- -------------------------------------------------------------- -------------------------------------------------------------- ------------------- ------------------- -------------- ------------ --------------
  Physical performance (m)                                                                                                                                                                                                                                                                                                                                                                                
   Mean±SD                   334.1±14.16                                                    444.25±21.83                                                                                                425±21.49                                                      338.38±14.12                                                   413.57±28.55        366.86±17.47        338.08±10.69   337±12.23    336.68±11.38
   *F* (*P*-value)                                                                          256.78 (\<0.01[\*](#tfn5-jer-15-3-472){ref-type="table-fn"},[†](#tfn6-jer-15-3-472){ref-type="table-fn"})                                                                                                                                                                                                     
                             502.1 (\<0.01[\*](#tfn5-jer-15-3-472){ref-type="table-fn"})                                                                                                                94.05 (\<0.01[\*](#tfn5-jer-15-3-472){ref-type="table-fn"})                                                                   1.97 (0.17^\*\*^)                                                   
                                                                                            168.49 (\<0.01[\*](#tfn5-jer-15-3-472){ref-type="table-fn"})                                                                                                               45.003 (\<0.01[\*](#tfn5-jer-15-3-472){ref-type="table-fn"})                       0.27 (0.61^\*\*^)                               
                             392.48 (\<0.01[\*](#tfn5-jer-15-3-472){ref-type="table-fn"})   70.74 (\<0.01[\*](#tfn5-jer-15-3-472){ref-type="table-fn"})                                                 2.39 (0.1^\*\*^)                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                          
  Functional balance                                                                                                                                                                                                                                                                                                                                                                                      
   Mean±SD                   41.15±2.35                                                     50.05±0.89                                                                                                  44.4±1.85                                                      40.95±2.25                                                     49.95±2.06          42.95±2.04          41.36±2.22     41.28±1.75   39.48±2.06
   *F* (*P*-value)                                                                          381.44 (\<0.05[\*](#tfn5-jer-15-3-472){ref-type="table-fn"},[†](#tfn6-jer-15-3-472){ref-type="table-fn"})                                                                                                                                                                                                     
                             342.82 (\<0.01[\*](#tfn5-jer-15-3-472){ref-type="table-fn"})                                                                                                               274.36 (\<0.05[\*](#tfn5-jer-15-3-472){ref-type="table-fn"})                                                                  0.1 (0.76^\*\*^)                                                    
                                                                                            222.38 (\<0.01[\*](#tfn5-jer-15-3-472){ref-type="table-fn"})                                                                                                               381.11 (\<0.05[\*](#tfn5-jer-15-3-472){ref-type="table-fn"})                       40.5 (0.06^\*\*^)                               
                             231.11 (\<0.01[\*](#tfn5-jer-15-3-472){ref-type="table-fn"})   240.51 (\<0.01[\*](#tfn5-jer-15-3-472){ref-type="table-fn"})                                                23.87 (0.07^\*\*^)                                                                                                                                                                                

AETG, aerobic exercise training group; RETG, resistance exercise training group; CG, control group; Eval, evaluation; SD, standard deviation.

*P*\<0.05, statistically significant difference.

Degree of freedom=2, 62.

###### 

Between-groups comparison of physical performance and functional balance (*F*, *P*-values)

                         Prestudy(Eval-1)   After 12 weeks (Eval-2)                                       Eight weeks poststudy (Eval-3)
  ---------------------- ------------------ ------------------------------------------------------------- -------------------------------------------------------------
  Physical performance   0.71, 0.5^\*\*^    152.1, \<0.01[\*](#tfn8-jer-15-3-472){ref-type="table-fn"}    153.81, \<0.01[\*](#tfn8-jer-15-3-472){ref-type="table-fn"}
  Functional balance     0.19, 0.83^\*\*^   215.11, \<0.01[\*](#tfn8-jer-15-3-472){ref-type="table-fn"}   36.87, \<0.01[\*](#tfn8-jer-15-3-472){ref-type="table-fn"}

Eval, evaluation.

*P*\<0.05, statistically significant difference.
